Kallepally Sudheer

Title: **Kallepally Sudheer: Innovator in Pharmaceutical Synthesis**

Introduction

Kallepally Sudheer, an inventive mind from Nalgonda, India, has made notable contributions to the field of pharmaceuticals. He is recognized for his innovative work and is the holder of a significant patent that enhances the synthesis process of key compounds used in medicine.

Latest Patents

Kallepally Sudheer holds a patent for the "Preparation of 3-[2-[4-((6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl)-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido[1,2-a]-pyrimidin-4-one (Paliperidone) and Paliperidone Palmitate." This patent presents an improved process for synthesizing Paliperidone and Paliperidone Palmitate through a novel intermediate known as (2-Chloroethyl)-6,7,8,9-tetrahydro-2-methyl-9-hydroxy-4H-pyrido[1,2-a]pyrimidine-4-one Palmitate ester.

Career Highlights

Despite operating under the umbrella of a company categorized as "Other," Kallepally has demonstrated exceptional capabilities in his work. He is dedicated to pushing the boundaries of pharmaceutical innovation through his research and development efforts.

Collaborations

Kallepally Sudheer has collaborated with notable professionals in his field, including Ramamohan Rao Davuluri and Ravi Ponnaiah. Together, they have contributed to advancements in pharmaceutical processes and have potentially paved the way for future innovations.

Conclusion

Kallepally Sudheer's inventive spirit and dedication to improving pharmaceutical synthesis are commendable. His patent reflects a significant advancement in the field and showcases his ability to innovate and collaborate effectively, marking him as a notable inventor in the pharmaceutical industry.